1416 Results

People

  1. Motzer
    Motzer
  2. Vickers
    Vickers
  3. Hudis
    Hudis
  4. Norton
    Norton
  5. Saltz
    Saltz
  6. O'Reilly
    O'Reilly
  7. Mao
    Mao
  8. Morris
    Morris
  9. Seidman
    Seidman
  10. Kris
    Kris

Groups

  1. Department of Medicine (753)
  2. Solid Tumor Oncology Division (541)
  3. Population Sciences Research Program (259)
  4. Survivorship Research (256)
  5. Surgery (244)
  6. Epidemiology and Biostatistics (187)
  7. Hematologic Malignancies, Division of (169)
  8. Genitourinary Oncology Service (160)
  9. Center for Hematologic Malignancies (142)
  10. Gastrointestinal Oncology Service (126)
  1. "randomized controlled trial"
Formats
  1. Journal Article (1353)
  2. Review (19)
  3. Conference Paper (17)
  4. Editorial (9)
  5. Correspondence (5)
  6. Research Letter (5)
  7. Meeting Abstract (4)
  8. Guidelines (3)
  9. Book Section (1)
Groups
  1. Department of Medicine (753)
  2. Solid Tumor Oncology Division (541)
  3. Population Sciences Research Program (259)
  4. Survivorship Research (256)
  5. Surgery (244)
  6. Epidemiology and Biostatistics (187)

More Groups

People
  1. Robert Motzer (83)
  2. Andrew Vickers (48)
  3. Larry Norton (34)
  4. Clifford Hudis (33)
  5. Leonard Saltz (32)
  6. Eileen O'Reilly (25)

More People

Years
  1. 2025 (63)
  2. 2024 (165)
  3. 2023 (110)
  4. 2022 (81)
  5. 2021 (39)
  6. 2020 (51)

More Years

Publications
  1. Journal of Clinical Oncology (164)
  2. New England Journal of Medicine (65)
  3. Lancet Oncology (46)
  4. Cancer (42)
  5. Clinical Cancer Research (42)
  6. European Urology (26)

More Publications

Publishers
  1. Elsevier Inc. (187)
  2. American Society of Clinical Oncology (170)
  3. Elsevier Science, Inc. (138)
  4. Springer (79)
  5. Lippincott Williams & Wilkins (72)
  6. Wiley Blackwell (71)

More Publishers

Results (1416)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A randomized phase II/III study of paclitaxel/carboplatin/metformin versus paclitaxel/carboplatin/placebo as initial therapy for measurable stage III or IVA, stage IVB, or recurrent endometrial cancer: An NRG oncology/GOG study
    Journal Article

    Bae-Jump, V. L.; Sill, M. W.; Gehrig, P. A.; Merker, J. D.; Corcoran, D. L.; Pfefferle, A. D.; Hayward, M. C.; Walker, J. L.; Hagemann, A. R.; Waggoner, S. E.; more...
    Gynecologic Oncology (2025)

    Fulltext@MSK | Save
  • REZILIENT3: Randomized phase III study of first-line zipalertinib plus chemotherapy in patients with EGFR exon 20 insertion-mutated NSCLC
    Journal Article

    Heymach, J. V.; Yu, H. A.; Besse, B.; Cheng, Y.; Tan, D. S. W.; Wei, L.; Wacheck, V.; Nishio, M.
    Future Oncology (2025)

    Fulltext@MSK | Save
  • Consensus recommendations from the 2024 Lymphoma Research Foundation workshop on treatment selection and sequencing in CLL or SLL
    Review

    Soumerai, J. D.; Barrientos, J.; Ahn, I.; Coombs, C.; Gladstone, D.; Hoffman, M.; Kittai, A.; Jacobs, R.; Lipsky, A.; Patel, K.; more...
    Blood Advances (2025)

    Fulltext@MSK | Save
  • The LYMPH trial: Comparing microsurgical with conservative treatment for chronic breast cancer-associated lymphoedema - Study protocol of a pragmatic randomised international multicentre superiority trial
    Journal Article

    Kappos, E. A.; Haas, Y.; Schulz, A.; Peters, F.; Savanthrapadian, S.; Stoffel, J.; Katapodi, M. C.; Mucklow, R.; Kaiser, B.; Haumer, A.; more...
    BMJ Open (2025)

    Fulltext@MSK | Save
  • The adverse event landscape of stem cell transplant: Evidence for AGVHD driving early transplant associated toxicities
    Journal Article

    Takahashi, T.; Watkins, B.; Bratrude, B.; Neuberg, D.; Hebert, K.; Betz, K.; Yu, A.; Choi, S. W.; Davis, J.; Duncan, C.; more...
    Transplantation and Cellular Therapy (2025)

    Fulltext@MSK | Save
  • SWOG S1815: A phase III randomized trial of gemcitabine, cisplatin, and nab-paclitaxel versus gemcitabine and cisplatin in newly diagnosed, advanced biliary tract cancers
    Journal Article

    Shroff, R. T.; King, G.; Colby, S.; Scott, A. J.; Borad, M. J.; Goff, L.; Matin, K.; Mahipal, A.; Kalyan, A.; Javle, M. M.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Adding metastasis-directed therapy to standard-of-care systemic therapy for oligometastatic breast cancer (EXTEND): A multicenter, randomized phase 2 trial
    Journal Article

    Reddy, J. P.; Sherry, A. D.; Fellman, B.; Liu, S.; Bathala, T.; Haymaker, C.; Cohen, L.; Smith, B. D.; Ramirez, D.; Shaitelman, S. F.; more...
    International Journal of Radiation Oncology, Biology, Physics (2025)

    Fulltext@MSK | Save
  • Clinical outcomes by baseline metastases in patients with renal cell carcinoma treated with lenvatinib plus pembrolizumab versus sunitinib: Post hoc analysis of the CLEAR trial
    Journal Article

    Grünwald, V.; McKay, R. R.; Buchler, T.; Eto, M.; Park, S. H.; Takagi, T.; Zanetta, S.; Keizman, D.; Suárez, C.; Négrier, S.; more...
    International Journal of Cancer (2025)

    Fulltext@MSK | Save
  • Optimizing accrual to a large-scale, clinically integrated randomized trial in anesthesiology: A 2-year analysis of recruitment
    Journal Article

    Tokita, H. K.; Assel, M.; Serafin, J.; Lin, E.; Sarraf, L.; Masson, G.; Moo, T. A.; Nelson, J. A.; Simon, B. A.; Vickers, A. J.
    Clinical Trials (2025)

    Fulltext@MSK | Save
  • The Society of Thoracic Surgeons (STS) clinical practice guideline on surgical management of oligometastatic non-small cell lung cancer
    Guidelines

    Antonoff, M. B.; Mitchell, K. G.; Kim, S. S.; Salfity, H. V.; Kotova, S.; Ripley, R. T.; Neri, A. L.; Sood, P.; Gandhi, S. G.; Elamin, Y. Y.; more...
    Annals of Thoracic Surgery (2025)

    Fulltext@MSK | Save